Financials

  • Market Capitalization 477.32 M
  • Employee 116
  • Founded 2013
  • CEO Shankar Musunuri
  • Website www.ocugen.com
  • Headquarter Delaware, United States
  • FIGI BBG00194VJB1
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.87
Rapporto prezzo/fatturato
91.83

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2935
NVCT
Nuvectis Pharma, Inc. - Common Stock
18.44 USD+0.49%-6.73%+68.56%+120.31%489.13 M USD
2938
PROK
ProKidney Corp. - Class A Ordinary Shares
1.61 USD-8.52%-21.08%-3.01%-22.60%486.32 M USD
2960
KYTX
Kyverna Therapeutics, Inc. - Common Stock
7.77 USD-8.48%-14.99%-5.47%+75.79%472.38 M USD
2961
VSTM
Verastem, Inc. - Common Stock
5.37 USD-2.89%+19.60%+29.09%+7.83%471.88 M USD

Notizie